 Connection
Xianzhong Meng to Dexmedetomidine
This is a "connection" page, showing publications Xianzhong Meng has written about Dexmedetomidine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.243 |
|
|
|
-
Freeman KA, Puskas F, Bell MT, Mares JM, Foley LS, Weyant MJ, Cleveland JC, Fullerton DA, Meng X, Herson PS, Reece TB. Alpha-2 agonist attenuates ischemic injury in spinal cord neurons. J Surg Res. 2015 May 01; 195(1):21-8.
Score: 0.116
-
Bell MT, Puskas F, Smith PD, Agoston VA, Fullerton DA, Meng X, Weyant MJ, Reece TB. Attenuation of spinal cord ischemia-reperfusion injury by specific a-2a receptor activation with dexmedetomidine. J Vasc Surg. 2012 Nov; 56(5):1398-402.
Score: 0.098
-
Freeman KA, Fullerton DA, Foley LS, Bell MT, Cleveland JC, Weyant MJ, Mares J, Meng X, Puskas F, Reece TB. Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line-derived neurotrophic factor. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):578-84; discussion 584-6.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|